Gene expression helps classify cancers.
Among 19 people with germinal-center B-like disease, 14 were still alive 5 years after diagnosis, he and his colleagues report in the Feb. 3 NATURE. In contrast, only 3 of 19 patients with so-called activated B-like disease survived for 5 years.
The team hopes that gene chips will illuminate the cellular pathways that give rise to the slightly different cancers and those results will lead to more successful therapies.
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||diffuse large B-cell lymphoma|
|Article Type:||Brief Article|
|Date:||Apr 8, 2000|
|Previous Article:||Antacids for asthma sufferers?|
|Next Article:||Telltale Dino Heart Hints at Warm Blood.|